Metyrapone as Additive Treatment in Major Depression
Authors:
- Holger JahnHJHolger Jahn
- Mildred SchickMSMildred Schick
- Falk KieferFKFalk Kiefer
- Michael KellnerMKMichael Kellner
- Alexander YassouridisAYAlexander Yassouridis
- Klaus WiedemannKWKlaus Wiedemann
Open Access
- 1 December 2004
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 61 (12) , 1235-1244
Abstract
Our understanding of the neuroendocrine pathophysiology of depressionhas made significant progress in recent years, which should help to developnew remedies. Alterations of the hypothalamic-pituitary-adrenal (HPA) axisare the most consistent pathological endocrine findings in depression.1-3 The key regulator ofHPA axis activity, corticotropin-releasing hormone (CRH), is increased indepression.4-6 Theeffects of CRH are modulated by neuropeptides7-9 andmonoaminergic transmitters.10,11 Theexaggerated HPA function in depression appears to be also the result of animpaired glucocorticoid receptor (GR)12,13 andmineralocorticoid receptor (MR)14,15 feedbackcontrol. Whether HPA-axis hyperactivity is initially caused by a CRH overdriveresulting in MR/GR dysfunction or vice versa by dysregulation at another levelis yet undecided.16,17Keywords
This publication has 17 references indexed in Scilit:
- Rapid Reversal of Psychotic Depression Using MifepristoneJournal of Clinical Psychopharmacology, 2001
- Limited Efficacy of Ketoconazole in Treatment-Refractory Major DepressionJournal of Clinical Psychopharmacology, 1999
- Treatment of Depression With Antiglucocorticoid DrugsPsychosomatic Medicine, 1999
- Metyrapone displays antidepressant-like properties in preclinical paradigmsPsychopharmacology, 1999
- Antiglucocorticoid treatment of depression: double-blind ketoconazoleBiological Psychiatry, 1999
- Corticosteroid Receptor Function Is Decreased in Depressed PatientsNeuroendocrinology, 1997
- Antiglucocorticoid treatment of refractory depression with ketoconazole: A case reportBiological Psychiatry, 1995
- Treatment of Major Depression with metyrapone and hydrocortisoneJournal of Affective Disorders, 1995
- Ketoconazole administration in hypercortisolemic depressionAmerican Journal of Psychiatry, 1993
- Treatment of major depression with steroid suppressive drugsThe Journal of Steroid Biochemistry and Molecular Biology, 1991